March 26, 2008 -- The offer to take Tongjitang Chinese Medicines (NYSE: TCM) private will be put in the lap of Morgan Stanley to determine whether the offer represents a fair price for the company. A special committee of the Board of Directors, composed of TCM’s two independent directors, appointed Morgan Stanley Asia Limited to be their financial advisor for the transaction. More details...
